Key statistics
On Friday, Vera Therapeutics Inc (VERA:NMQ) closed at 42.22, -24.67% below its 52-week high of 56.05, set on Dec 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 42.74 |
|---|---|
| High | 44.03 |
| Low | 42.07 |
| Bid | 41.55 |
| Offer | 43.29 |
| Previous close | 42.24 |
| Average volume | 988.23k |
|---|---|
| Shares outstanding | 70.03m |
| Free float | 69.23m |
| P/E (TTM) | -- |
| Market cap | 2.96bn USD |
| EPS (TTM) | -3.98 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Announcements
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
- Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
- Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors
- Vera Therapeutics to Participate at Upcoming Investor Conferences
More ▼
